Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,725.10
+32.30 (1.91%)
Jul 13, 2026, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 282.8 billion as of July 13, 2026. Its market cap has increased by 16.22% in one year.
Market Cap
282.80B
Enterprise Value
271.81B
Revenue
27.63B
Ranking
n/a
PE Ratio
56.05
Stock Price
1,725.10
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 282.80B, an increase of 314.77%. That is a compound annual growth rate of 14.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 288.20B | 16.33% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.64T |
| Divi's Laboratories | 1.81T |
| Apollo Hospitals Enterprise | 1.27T |
| Cipla | 1.16T |
| Global Health | 359.45B |
| Emcure Pharmaceuticals | 343.99B |
| Inventurus Knowledge Solutions | 330.88B |
| Krishna Institute of Medical Sciences | 326.07B |